High-content screening in infectious diseases

Current Opinion in Chemical Biology

Volumn 15, Issue 4, 2011, Pages 534-539

  Brodin, Priscille ^a,c   Christophe, Thierry ^b,d  

^a Biology of Intracellular Pathogens Inserm Avenir Team   (South Korea)

^b Screening Technologies and Pharmacology   (South Korea)

^c UNIV LILLE   (France)

^d GALAPAGOS NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HOST FACTOR;

AUTOMATION; BACTERIOLOGY; CELL ACTIVITY; CELL MIGRATION; DRUG DETERMINATION; GENETIC SCREENING; HIGH CONTENT SCREENING; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; HUMAN; IMAGE ANALYSIS; INFECTION; NONHUMAN; PARASITOLOGY; REVIEW; RNA INTERFERENCE; SCREENING;

ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; COMMUNICABLE DISEASES; DRUG DISCOVERY; GENETIC TESTING; HIGH-THROUGHPUT SCREENING ASSAYS; HOST-PATHOGEN INTERACTIONS; HUMANS; MINIATURIZATION; RNA INTERFERENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960986078     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.05.023     Document Type: Review

References (38)

1. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
2. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., Daszak P. Global trends in emerging infectious diseases. Nature 2008, 451:990-993.
3. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
4. Zanella F., Lorens J.B., Link W. High content screening: seeing is believing. Trends Biotechnol 2010, 28:237-245.
5. Ramirez C.N., Ozawa T., Takagi T., Antczak C., Shum D., Graves R., Holland E.C., Djaballah H. Validation of a high-content screening assay using whole-well imaging of transformed phenotypes. Assay Drug Dev Technol 2010.
6. Perlman Z.E., Slack M.D., Feng Y., Mitchison T.J., Wu L.F., Altschuler S.J. Multidimensional drug profiling by automated microscopy. Science 2004, 306:1194-1198.
7. Collinet C., Stoter M., Bradshaw C.R., Samusik N., Rink J.C., Kenski D., Habermann B., Buchholz F., Henschel R., Mueller M.S., et al. Systems survey of endocytosis by multiparametric image analysis. Nature 2010, 464:243-249.
8. Rausch O. High content cellular screening. Curr Opin Chem Biol 2006, 10:316-320.
9. Bickle M. The beautiful cell: high-content screening in drug discovery. Anal Bioanal Chem 2010, 398:219-226.
10. Korn K., Krausz E. Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 2007, 11:503-510.
11. Agaisse H., Burrack L.S., Philips J.A., Rubin E.J., Perrimon N., Higgins D.E. Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science 2005, 309:1248-1251.
12. Philips J.A., Rubin E.J., Perrimon N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 2005, 309:1251-1253.
13. Derre I., Pypaert M., Dautry-Varsat A., Agaisse H. RNAi screen in Drosophila cells reveals the involvement of the Tom complex in Chlamydia infection. PLoS Pathog 2007, 3:1446-1458.
14. Christophe T., Ewann F., Jeon H.K., Cechetto J., Brodin P. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Future Med Chem 2010, 2:1283-1293.
15. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
16. Li Q., Brass A.L., Ng A., Hu Z., Xavier R.J., Liang T.J., Elledge S.J. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A 2009, 106:16410-16415.
17. Coller K.E., Berger K.L., Heaton N.S., Cooper J.D., Yoon R., Randall G. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 2009, 5:e1000702.
18. Krishnan M.N., Ng A., Sukumaran B., Gilfoy F.D., Uchil P.D., Sultana H., Brass A.L., Adametz R., Tsui M., Qian F., et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 2008, 455:242-245.
19. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
20. Barrows N.J., Le Sommer C., Garcia-Blanco M.A., Pearson J.L. Factors affecting reproducibility between genome-scale siRNA-based screens. J Biomol Screen 2010, 15:735-747.
21. Westby M., Nakayama G.R., Butler S.L., Blair W.S. Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors. Antiviral Res 2005, 67:121-140.
22. Berke J.M., Fenistein D., Pauwels F., Bobbaers R., Lenz O., Lin T.I., Krausz E., Fanning G. Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex. J Virol Methods 2010, 165:268-276.
23. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999, 4:67-73.
24. Shum D., Smith J.L., Hirsch A.J., Bhinder B., Radu C., Stein D.A., Nelson J.A., Fruh K., Djaballah H. High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol 2010, 8:553-570.
25. Panchal R.G., Kota K.P., Spurgers K.B., Ruthel G., Tran J.P., Boltz R.C., Bavari S. Development of high-content imaging assays for lethal viral pathogens. J Biomol Screen 2010, 15:755-765.
26. Kuijl C., Savage N.D., Marsman M., Tuin A.W., Janssen L., Egan D.A., Ketema M., van den Nieuwendijk R., van den Eeden S.J., Geluk A., et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007, 450:725-730.
27. Fenistein D., Lenseigne B., Christophe T., Brodin P., Genovesio A. A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening. Cytometry A 2008, 73:958-964.
28. Moon H., Genovesio A. IM, a computing approach for image mining of high throughput-high content screening. Abstract 2008, 334-339.
29. Christophe T., Jackson M., Jeon H.K., Fenistein D., Contreras-Dominguez M., Kim J., Genovesio A., Carralot J.P., Ewann F., Kim E.H., et al. High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog 2009, 5:e1000645.
30. Flipo M., Desroses M., Lecat-Guillet N., Dirie B., Carette X., Leroux F., Piveteau C., Demirkaya F., Lens Z., Rucktooa P., et al. Ethionamide boosters: synthesis, biological activity and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. J Med Chem 2011.
31. Guiguemde W.A., Shelat A.A., Bouck D., Duffy S., Crowther G.J., Davis P.H., Smithson D.C., Connelly M., Clark J., Zhu F., et al. Chemical genetics of Plasmodium falciparum. Nature 2010, 465:311-315.
32. Siqueira-Neto J.L., Song O.R., Oh H., Sohn J.H., Yang G., Nam J., Jang J., Cechetto J., Lee C.B., Moon S., et al. Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. PLoS Negl Trop Dis 2010, 4:e675.
33. Chatelain E., Loset J.R. Drug discovery and development for neglected diseases: the DNDi model. Drug Des Dev Ther 2011, 5:175-181.
34. Peach K.C., Bray W.M., Shikuma N.J., Gassner N.C., Lokey R.S., Yildiz F.H., Linington R.G. An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. Mol Biosyst 2011, 7:1176-1184.
35. Mayr L.M., Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009, 9:580-588.
36. Lang P., Yeow K., Nichols A., Scheer A. Cellular imaging in drug discovery. Nat Rev Drug Discov 2006, 5:343-356.
37. Bozzaro S., Eichinger L. The professional phagocyte Dictyostelium discoideum as a model host for bacterial pathogens. Curr Drug Targets 2011.
38. Carvalho R., de Sonneville J., Stockhammer O.W., Savage N.D., Veneman W.J., Ottenhoff T.H., Dirks R.P., Meijer A.H., Spaink H.P. A high-throughput screen for tuberculosis progression. PLoS One 2011, 6:e16779.